Rotem Merose
Shamir, Z, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Vitiligo-like leukoderma following treatment with cyclin-dependent kinase 4/6 inhibitors - analysis of clinicopathologic and immunohistochemical findings.
Journal: Clinical and experimental dermatology
Published: June 24, 2025
Vitiligo-like leucoderma following treatment with cyclin-dependent kinase 4 and 6 inhibitors: analysis of clinicopathological and immunohistochemical findings.
Journal: Clinical and experimental dermatology
Published: June 24, 2025
Prolonged response to PIK3CA inhibition in an advanced hormone-positive breast cancer patient with 3 mutations in the alpha subunit of PI-3 kinase.
Journal: The oncologist
Published: December 25, 2024
Vitiligo-like leucoderma following cyclin-dependent kinase 4 and 6 inhibitor treatment: systematic review of the literature.
Journal: Clinical and experimental dermatology
Published: November 14, 2024
ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.
Journal: Breast cancer research and treatment
Published: June 11, 2024
Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study.
Journal: NPJ breast cancer
Published: November 23, 2022
GERIATRIC ONCOLOGY - CANCER TREATMENT IN OLDER ADULTS AND OLDEST-OLD
Journal: Harefuah
Published: January 25, 2022
Weekly Carboplatin and Paclitaxel: A Retrospective Comparison with the Three-Weekly Schedule in First-Line Treatment of Ovarian Cancer.
Journal: The oncologist
Published: March 10, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026